in doubt if there was a temperature excursion and if were administered/temperature excursion exposed to 34.1 F-up to 59 F for 80 hours; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, Flu Seasonal QIV (FluLaval Quadrivalent 2021-2022 season) for prophylaxis, flu seasonal qiv pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis, dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAV (Havrix) for prophylaxis, hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis, Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) for prophylaxis, flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis, Rota (Rotarix lyophilized formulation) for prophylaxis, rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis, HBV (Engerix B) for prophylaxis and hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero, Bexsero Pre-Filled Syringe Device, FluLaval Quadrivalent 2021-2022 season, Flulaval Tetra Pre-Filled Syringe Device, Kinrix, Kinrix Pre-Filled Syringe Device, Havrix, Havrix Pre-Filled Syringe Device, Fluarix Quadrivalent 2021-2022 season, Fluarix Tetra Pre-Filled Syringe Device, Rotarix lyophilized formulation, Rotarix Oral Applicator Device, Menveo, Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero, Bexsero Pre-Filled Syringe Device, FluLaval Quadrivalent 2021-2022 season, Flulaval Tetra Pre-Filled Syringe Device, Kinrix, Kinrix Pre-Filled Syringe Device, Havrix, Havrix Pre-Filled Syringe Device, Fluarix Quadrivalent 2021-2022 season, Fluarix Tetra Pre-Filled Syringe Device, Rotarix lyophilized formulation, Rotarix Oral Applicator Device, Menveo, Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. The action taken with Flulaval Tetra Pre-Filled Syringe Device was unknown. The action taken with Kinrix Pre-Filled Syringe Device was unknown. The action taken with Havrix Pre-Filled Syringe Device was unknown. The action taken with Fluarix Tetra Pre-Filled Syringe Device was unknown. The action taken with Rotarix Oral Applicator Device was unknown. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  The age at vaccination was not applicable for this report. The reporter reported that the vaccines involved were Bexsero, Flulaval, Kinrix, Havrix, Fluarix, Rotarix, Menveo, Engerix-b were exposed to 34.1 degree F up to 59 degree F for 80 hours, which led to incorrect storage of drug. The health care professional (HCP) seemed confused about the dates and in doubt if there was an actual temperature excursion and asked what if they administered these vaccines to patients. The vaccine administration facility is the same as primary reporter. Upon clarification HCP was not able to confirm if this happened or not and stated he/she would have to ask his/her boss. No consent was asked as HCP wanted to end conversation. No more details provided.